Skip to main content

Advertisement

SpringerLink
Log in

New-onset partial epilepsy in adults

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Medical management, the mainstay of treatment for partial epilepsy, involves choosing from an array of antiseizure drugs, most of which have comparable efficacy against partial-onset seizures. Effective treatment strategies involve matching the characteristics of drug and patient to control seizures without adverse effects, a task that requires familiarity with the potential advantages and drawbacks of individual antiseizure drugs. For medically refractory partial epilepsy, resective surgical procedures should be considered. If the patient is not a surgical candidate, the vagus nerve stimulator or ketogenic diet may improve seizure control in selected cases. Emerging therapies include medications with novel mechanisms of action, deep brain stimulators, and cortical stimulators that respond to neural patterns of seizure activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Begley CE, Famulari M, Annegers JF, et al.: The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41:342–351.

    Article  PubMed  CAS  Google Scholar 

  2. Kim LG, Johnson TL, Marson AG, Chadwick DW; MRC MESS Study Group: Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006, 5:317–322.

    Article  PubMed  Google Scholar 

  3. Marson A, Jacoby A, Johnson A, et al.: Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005, 365:2007–2013.

    Article  PubMed  CAS  Google Scholar 

  4. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group). Neurology 1993, 43:478–483.

  5. Musicco M, Beghi E, Solari A, Viani F: Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology 1997, 49:991–998.

    PubMed  CAS  Google Scholar 

  6. Krumholz A, Wiebe S, Gronseth G, et al.: Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Neurology 2007, 69:1996–2007.

    Article  PubMed  CAS  Google Scholar 

  7. Harden CL, Huff JS, Schwartz TH, et al.: Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2007, 69:1772–1780.

    Article  PubMed  CAS  Google Scholar 

  8. Ross SD, Estok R, Chopra S, et al.: Management of newly diagnosed patients with epilepsy: a systematic review of the literature. Evidence Report/Technology Assessment No. 39. AHRQ Publication No. 01-E038. Rockville, MD: Agency for Healthcare Research and Quality; 2001.

    Google Scholar 

  9. Hirtz D, Ashwal S, Berg A, et al.: Practice parameter: evaluating a first nonfebrile seizure in children. Neurology 2000, 55:616–623.

    PubMed  CAS  Google Scholar 

  10. French JA, Kanner AM, Bautista J, et al.: Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1252–1260.

    PubMed  CAS  Google Scholar 

  11. Glauser T, Ben-Menachem E, Bourgeois B, et al.: ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006, 47:1094–1120.

    Article  PubMed  Google Scholar 

  12. Birbeck G, Hays RD, Cui X, et al.: Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002, 43:535–538.

    Article  PubMed  Google Scholar 

  13. Karceski S, Morrell MJ, Carpenter D: Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav 2005, 7(Suppl 1):S1–S64.

    Article  PubMed  Google Scholar 

  14. Kwan P, Brodie MJ: Effectiveness of first antiepileptic drug. Epilepsia 2001, 42:1255–1260.

    Article  PubMed  CAS  Google Scholar 

  15. Berg AT, Langfitt J, Shinnar S, et al.: How long does it take for partial epilepsy to become intractable? Neurology 2003, 60:186–190.

    PubMed  CAS  Google Scholar 

  16. Luciano AL, Shorvon SD: Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007, 62:375–381.

    Article  PubMed  CAS  Google Scholar 

  17. Callaghan BC, Anand K, Hesdorffer D, et al.: Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007, 62:382–389.

    Article  PubMed  Google Scholar 

  18. Deckers CLP, Grenton P, Sills GJ, Schmidt D: Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res 2003, 53:1–17.

    Article  PubMed  CAS  Google Scholar 

  19. Shorvon S: Handbook of Epilepsy Treatment. Oxford: Blackwell Science; 2000.

    Google Scholar 

  20. Hung SL, Chung WH, Jee SH, et al.: Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006, 16:297–306.

    Article  PubMed  CAS  Google Scholar 

  21. Kamaliah MD, Zainal D, Mokhtar N, et al.: Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia. Int J Dermatol 1998, 37:520–523.

    Article  PubMed  CAS  Google Scholar 

  22. Man CBL, Kwan P, Baum L, et al.: Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007, 48:1015–1018.

    Article  PubMed  CAS  Google Scholar 

  23. Froscher W, Eichelbaum M, Gugler R, et al.: A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy. J Neurol 1981, 224:193–201.

    Article  PubMed  CAS  Google Scholar 

  24. Woo E, Chan YM, Yu YL, et al.: If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study. Epilepsia 1988, 29:129–139.

    Article  PubMed  CAS  Google Scholar 

  25. Jannuzzi G, Cian P, Fattore C, et al.: A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Epilepsia 2000, 41:222–230.

    Article  PubMed  CAS  Google Scholar 

  26. Mattson RH, Gidal BE: Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 2004, 5(Suppl 2):S36–S40.

    Article  PubMed  Google Scholar 

  27. Andress DL, Ozuna J, Tirschwell D, et al.: Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002, 59:781–786.

    Article  PubMed  Google Scholar 

  28. Petty SJ, Paton LM, O’Brien TJ, et al.: Effect of antiepileptic drug medication on bone mineral measures. Neurology 2005, 65:1358–1365.

    Article  PubMed  CAS  Google Scholar 

  29. Ensrud KE, Walczak TS, Blackwell T, et al.: Antiepileptic drug increases rates of bone loss in older women: a prospective study. Neurology 2004, 62:2051–2057.

    PubMed  CAS  Google Scholar 

  30. Pack AM: Bone health in people with epilepsy: Is it impaired and what are the risk factors? Seizure 2008, 17:181–186.

    Article  PubMed  Google Scholar 

  31. Souverein PC, Webb DJ, Weil JG, et al.: Use of antiepileptic drugs and risk of fractures: case control study among patients with epilepsy. Neurology 2006, 66:1318–1324.

    Article  PubMed  CAS  Google Scholar 

  32. Mikati MA, Dib L, Yamout B, et al.: Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology 2006, 67:2005–2014.

    Article  PubMed  CAS  Google Scholar 

  33. Ficker DM, Privitera M, Krauss G, et al.: Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. Neurology 2005, 65:593–595.

    Article  PubMed  CAS  Google Scholar 

  34. Hakimi AS, Spanaki MV, Schuh LA, et al.: A survey of neurologists’ views on epilepsy surgery and medically refractory epilepsy. Epilepsy Behav 2008, 13:96–101.

    Article  PubMed  Google Scholar 

  35. Engel J, Wiebe S, French J. et al.: Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003, 60:538–547.

    PubMed  Google Scholar 

  36. Langfitt JT, Weibe S: Early surgical treatment for epilepsy. Curr Opin Neurol 2008, 21:179–183.

    Article  PubMed  Google Scholar 

  37. Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S: Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007, 130:334–345.

    Article  PubMed  Google Scholar 

  38. Spencer S: Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008, 7:525–537.

    Article  PubMed  Google Scholar 

  39. Wiebe S, Blume WT, Girvin JP, Eliasziw M: A randomized controlled trial of surgery for temporal lobe epilepsy. N Engl J Med 2001, 345:311–318.

    Article  PubMed  CAS  Google Scholar 

  40. Tanriverdi T, Olivier A, Poulin N, et al.: Long-term seizure outcome after mesial temporal lobe epilepsy surgery: corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg 2008, 108:517–524.

    Article  PubMed  Google Scholar 

  41. Schramm J: Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review. Epilepsia 2008, 49:1296–1307.

    PubMed  Google Scholar 

  42. Benifla M, Otsubo H, Ochi A, et al.: Multiple subpial transections in pediatric epilepsy: indications and outcomes Childs Nerv Syst 2006, 22:992–998.

    Article  PubMed  Google Scholar 

  43. Schuele SU, Lüders HO: Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol 2008, 7:514–524.

    Article  PubMed  Google Scholar 

  44. Ardesch JJ, Buschman HP, Wagener-Schimmel LJ, et al.: Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study. Seizure 2007, 16:579–585.

    Article  PubMed  CAS  Google Scholar 

  45. Cross JH, Neal EG: The ketogenic diet: update on recent clinical trials. Epilepsia 2008, 49(Suppl 8):6–10.

    Article  PubMed  Google Scholar 

  46. Malow BA, Foldvary-Schaefer N, Vaughn BV, et al.: Treating obstructive sleep apnea in adults with epilepsy: a randomized pilot trial. Neurology 2008, 71:572–577.

    Article  PubMed  CAS  Google Scholar 

  47. Foldvary-Schaefer N, Grigg-Damberger M: Sleep and epilepsy: what we know, don’t know, and need to know. J Clin Neurophysiol 2006, 23:4–20.

    Article  PubMed  Google Scholar 

  48. Conry JA, Pearl PL: Herbal therapy in epilepsy. In Complementary and Alternative Therapies for Epilepsy. Edited by Devinsky O, Schachter S, Pacia S. New York: Demos Medical Publishing; 2005:129–142.

    Google Scholar 

  49. Haller CA, Meier KH, Olson KR: Seizures reported with dietary supplements. Clin Toxicol 2005, 43:23–30.

    Google Scholar 

  50. Tyagi A, Delanty N: Herbal remedies, dietary supplements, and seizures. Epilepsia 2003, 44:228–235.

    Article  PubMed  Google Scholar 

  51. Gordon E, Devinsky O: Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 2001, 42:1266–1272.

    Article  PubMed  CAS  Google Scholar 

  52. McIntosh C, Chick J: Alcohol and the nervous system. J Neurol Neurosurg Psychiatry 2004, 7(Suppl III):16–21.

    Google Scholar 

  53. Data from Pivotal Study Show Medtronic Deep Brain Stimulation Therapy Reduced Seizure Rate in Patients with Severe Epilepsy [news release]. Minneapolis, MN: Medtronic, Inc.; December 8, 2008. Accessed February 2009.

  54. Morrell M: Brain stimulation for epilepsy: Can scheduled or responsive neurostimulation stop seizures? Curr Opin Neurol 2006, 19:164–168.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Rochester Medical Center, 601 Elmwood Avenue, Box 673, Rochester, NY, 14642, USA

    Lynn Liu

Authors
  1. Lynn Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Craig Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lynn Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, L., Henry, J.C. New-onset partial epilepsy in adults. Curr Treat Options Neurol 11, 242–252 (2009). https://doi.org/10.1007/s11940-009-0028-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-009-0028-2

Keywords

Search

Navigation